TY - JOUR
T1 - Expansion of donor-reactive host T cells in primary graft failure after allogeneic hematopoietic SCT following reduced-intensity conditioning
AU - Koyama, M.
AU - Hashimoto, D.
AU - Nagafuji, K.
AU - Eto, T.
AU - Ohno, Y.
AU - Aoyama, K.
AU - Iwasaki, H.
AU - Miyamoto, T.
AU - Hill, G. R.
AU - Akashi, K.
AU - Teshima, T.
N1 - Funding Information:
We thank the patients and their families who participated in these clinical trials and the inpatient and outpatient bedside nurses who provided expert care on a daily basis to these patients at our institution. This study was supported by JSPS KAKENHI (25293217 to TT), and Health and Labor Science Research Grants (TT). We thank Dr Steven Lane and Dr Claudia Bruedigam, QIMR, for expert technical assistance with stem cell assays.
PY - 2014
Y1 - 2014
N2 - Graft rejection remains a major obstacle in allogeneic hematopoietic SCT following reduced-intensity conditioning (RIC-SCT), particularly after cord blood transplantation (CBT). In a murine MHC-mismatched model of RIC-SCT, primary graft rejection was associated with activation and expansion of donor-reactive host T cells in peripheral blood and BM early after SCT. Donor-derived dendritic cells are at least partly involved in host T-cell activation. We then evaluated if such an expansion of host T cells could be associated with graft rejection after RIC-CBT. Expansion of residual host lymphocytes was observed in 4/7 patients with graft rejection at 3 weeks after CBT, but in none of the 17 patients who achieved engraftment. These results suggest the crucial role of residual host T cells after RIC-SCT in graft rejection and expansion of host T cells could be a marker of graft rejection. Development of more efficient T cell-suppressive conditioning regimens may be necessary in the context of RIC-SCT.
AB - Graft rejection remains a major obstacle in allogeneic hematopoietic SCT following reduced-intensity conditioning (RIC-SCT), particularly after cord blood transplantation (CBT). In a murine MHC-mismatched model of RIC-SCT, primary graft rejection was associated with activation and expansion of donor-reactive host T cells in peripheral blood and BM early after SCT. Donor-derived dendritic cells are at least partly involved in host T-cell activation. We then evaluated if such an expansion of host T cells could be associated with graft rejection after RIC-CBT. Expansion of residual host lymphocytes was observed in 4/7 patients with graft rejection at 3 weeks after CBT, but in none of the 17 patients who achieved engraftment. These results suggest the crucial role of residual host T cells after RIC-SCT in graft rejection and expansion of host T cells could be a marker of graft rejection. Development of more efficient T cell-suppressive conditioning regimens may be necessary in the context of RIC-SCT.
UR - http://www.scopus.com/inward/record.url?scp=84891848251&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84891848251&partnerID=8YFLogxK
U2 - 10.1038/bmt.2013.134
DO - 10.1038/bmt.2013.134
M3 - Article
C2 - 24013691
AN - SCOPUS:84891848251
SN - 0268-3369
VL - 49
SP - 110
EP - 115
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
IS - 1
ER -